Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease
Sponsor: Tourmaline Bio, Inc.
Summary
Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight weeks to TED patients who are in the active inflammatory phase of disease.
Official title: A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
79
Start Date
2024-02-19
Completion Date
2027-09
Last Updated
2026-04-23
Healthy Volunteers
No
Conditions
Interventions
TOUR006 - 20 MG
TOUR006 20 MG
Placebo
Placebo
TOUR006 - 50 MG
TOUR006 - 50 MG
Locations (36)
Catalina Eye Care - Site 840-121
Tucson, Arizona, United States
Foothill Eye Institute - Site 840-116
Pasadena, California, United States
University of California Davis Eye Center - Site 840-119
Sacramento, California, United States
The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122
San Francisco, California, United States
UC Hospital Sue Anschulz-Rodgers Eye Center - Site 840-101
Aurora, Colorado, United States
Bascom Palmer Eye Institute - Site 840-115
Miami, Florida, United States
Ophthalmic Consultants of Boston - Site 840-128
Boston, Massachusetts, United States
Kahana Oculoplastic and Orbital Surgery - Site 840-112
Livonia, Michigan, United States
Ophthalmic Plastic, Reconstructive, Orbital & Cosmetic Surgery - Site 840-123
Las Vegas, Nevada, United States
Hackensack University Medical Center - Site 840-105
Hackensack, New Jersey, United States
Columbia University - Site 840-125
New York, New York, United States
Academy of Diabetes, Thyroid, and Endocrine - Site 840-129
El Paso, Texas, United States
DCT Fort Worth Research Center - Site 840-133
Fort Worth, Texas, United States
Sun Research Institute - Site 840-120
San Antonio, Texas, United States
University of West Virginia - Site 840-113
Morgantown, West Virginia, United States
Freire Pesquisa Clinica - Site 076-773
Belo Horizonte, Brazil
UFG - Hospital de Clinicas da Universidade Federal de Goias - Site 076-762
Goiânia, Brazil
Santa Casa de Misericordia de Porto Alegre - Site 076-767
Porto Alegre, Brazil
Universidade Federal do Rio Grande do Sul (UFRGS) - Site 076-775
Porto Alegre, Brazil
NPCRS - Nucleo de Pesquisa Clinica do Rio Grande do Sul - Site 076-764
Porto Alegre, Brazil
Centro Brasileiro de Pesquisa Clínica - Rio de Janeiro Ltd - Site 076-765
Rio de Janeiro, Brazil
Irmandade da Santa Casa de Misericordia de Sao Paulo - Site 076-771
São Paulo, Brazil
IPEPO - Instituto Paulista de Estudos e Pesquisas em Oftalmologia - Site 076-761
São Paulo, Brazil
CHU Angers - Site 250-252
Angers, France
CHU de Nantes - Hopital Nord Laennec - Site 250-251
Nantes, France
Azienda Ospedaliera Universitaria Federico II - Site 390-382
Naples, Italy
Azienda Ospedaliero Universitaria Pisana - Site 380-381
Pisa, Italy
Al-Essra Hospital - Site 400-401
Amman, Jordan
Riga East Clinical University Hospital, Clinic Bikernieki - Site 428-901
Riga, Latvia
Ziemelkurzemes Regional Hospital - Site 428-902
Ventspils, Latvia
Southern Eye Specialists Ltd - Site 554-501
Christchurch, New Zealand
University of Puerto Rico, Medical Sciences Campus - Site 630-602
San Juan, Puerto Rico
Univerzitna nemocnica Bratislava - Nemocnica sv. Cyrila a Metoda - Site 703-211
Bratislava, Slovakia
Seoul National University Hospital - Site 410-002
Seoul, South Korea
Hospital Universitario Ramon y Cajal - Site 724-803
Madrid, Spain
Hospital Universitario Virgen Macarena - Site 724-801
Seville, Spain